Biohit Oyj

Director's Dealing • Mar 3, 2017

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:05 am local time (EET)

Person subject to the notification requirement
Name: Hendolin, Panu
Position: Other senior manager

---

Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170302112710_1

---

Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29

---

Transaction details
Transaction date: 2017-03-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 2102
Unit price: 3,04340 Euro

Aggregated transactions
Volume: 2102
Volume weighted average price: 3.04340 Euro

---

Transaction details
Transaction date: 2017-03-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Subscription
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 774
Unit price: 2,27660 Euro

Aggregated transactions
Volume: 774
Volume weighted average price: 2.27660 Euro

---

Transaction details
Transaction date: 2017-03-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Disposal
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 774
Unit price: 0,00000 Euro

Aggregated transactions
Volume: 774
Volume weighted average price: 0.00000 Euro

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com